Catalan
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
docosahexaenoic acid/càncer de mama
L'enllaç es desa al porta-retalls
11 resultats
Adaptive Symptom Care Using Fish-Based Nutritional Directives Post Breast Cancer
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
Docosahexaenoic Acid (DHA) for Women With Breast Cancer in the Neoadjuvant Setting
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
Observational STudy to Evaluate the EFfectiveness of OnLife® in Improving CIPN in Patients With Colon or Breast Cancer After End of Adj. Therapy
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
CIPN is a common side effect of many chemotherapeutic agents and often results in dose limitation, switch to less efficacious agents or even therapy discontinuation. CIPN mainly affects sensory nerves, while motor or autonomic nerve injury is rare. Therefore, most patients with CIPN experience
Omega 3 Fatty Acids and ERPR(-)HER2(+/-) Breast Cancer Prevention
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
The study aims to determine biological changes that occur with a 12 month intervention of low (~0.9 g EPA+DHA/day) vs high dose (~5.4 g EPA+DHA/day) of omega 3 polyunsaturated fatty acids (PUFAs) in women survivors of hormone unresponsive breast cancer. The objectives of the trial are to develop
VITamin D and OmegA-3 TriaL: Effects on Mammographic Density and Breast Tissue
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
Mammographic density is one of the strongest risk factors for breast cancer. It is predictive of breast cancer risk for at least 10 years in the futue and has been suggested as a surrogate marker of breast cancer risk. Several states now mandate release of mammographic density data to women.
Docosahexaenoic Acid in Preventing Recurrence in Breast Cancer Survivors
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
PRIMARY OBJECTIVES:
I. To determine whether treatment with docosahexaenoic acid (DHA) for 12 weeks at 1000 mg twice daily as compared to placebo reduces normal breast tissue levels of tumor necrosis factor-alpha (TNF-alpha) in overweight and obese patients with a history of stage I-III invasive
A Randomised Study of Docosahexaenoic Acid (DHA) in Metastatic Breast Cancer
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
Local relapses and metastases make breast cancer a deadly disease. A major goal remains the improvement of treatment efficacy, meaning increasing toxicity to tumor tissue, without additional toxicity to non-tumor tissues.
The literature indicates that DHA sensitizes breast malignant tumors, but not
S0927:Omega3-Fatty Acid Supp in Treating Muscle&Bone Pain&Stiffness in Pts W/Stg I,II,III Brst Canc Rec'v Hormone Thpy
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
OBJECTIVES:
Primary
- To assess whether omega-3-fatty acid as compared to placebo causes a reduction in worst joint pain and/or stiffness at 12 weeks, as measured by the modified Brief Pain Inventory (BPI), in women with early-stage breast cancer and aromatase inhibitor (AI)-associated
Breast Cancer Risk Biomarkers in Postmenopausal Women
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
The central hypothesis is that 6 months of administration of high dose omega-3 fatty acid esters [eicosapentaenoic acid (EPA) 1860 mg, and docosahexaenoic acid (DHA) 1500 mg] daily in the form of a standard prescription strength dose of Lovaza™ (two 1 gram capsules twice daily) will have a favorable
Breast Cancer Risk Biomarkers in Premenopausal Women
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
The central hypothesis is that 6 months of administration of high dose omega-3 fatty acid esters [eicosapentaenoic acid (EPA) 1860 mg, and docosahexaenoic acid (DHA) 1500 mg] daily in the form of a standard prescription strength dose of Lovaza™ (two 1 gram capsules twice daily) will have a favorable
A Pilot Study of Docosahexaenoic Acid (DHA) in Obese Menopausal Women
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
Breast cancer is one of the most frequently seen cancers in the United States. Breast cancer occurs at all ages but is particularly common in post menopausal women. Obesity increases the risk of breast cancer primarily of the type that is stimulated by the female sex hormone estrogen. In obesity,
La base de dades d’herbes medicinals més completa avalada per la ciència
- Funciona en 55 idiomes
- Cures a base d'herbes recolzades per la ciència
- Reconeixement d’herbes per imatge
- Mapa GPS interactiu: etiqueta les herbes a la ubicació (properament)
- Llegiu publicacions científiques relacionades amb la vostra cerca
- Cerqueu herbes medicinals pels seus efectes
- Organitzeu els vostres interessos i estigueu al dia de les novetats, els assajos clínics i les patents
Escriviu un símptoma o una malaltia i llegiu sobre herbes que us poden ajudar, escriviu una herba i vegeu malalties i símptomes contra els quals s’utilitza.
* Tota la informació es basa en investigacions científiques publicades
